

Acurx Pharmaceuticals (NASDAQ:ACXP) shares down on Friday after reporting net loss for Q4 2025, but with positive cash and $1.5M raised.
You can purchase shares of Acurx Pharmaceuticals (NASDAQ:ACXP) through any online brokerage.
There are no as such competitors for Acurx Pharmaceuticals.
Acurx Pharmaceuticals has a consensus price target of $143.67.
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.0954 last updated October 26, 2026 at 5:28 PM EDT.
There are no upcoming dividends for Acurx Pharmaceuticals.
Acurx Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acurx Pharmaceuticals.
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive...